IRIS
BREMBILLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.423
NA - Nord America 1.654
AS - Asia 1.564
SA - Sud America 206
Continente sconosciuto - Info sul continente non disponibili 194
AF - Africa 33
OC - Oceania 10
Totale 6.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.567
RU - Federazione Russa 1.236
IT - Italia 705
SG - Singapore 527
CN - Cina 458
BR - Brasile 162
BD - Bangladesh 156
HK - Hong Kong 155
VN - Vietnam 112
FR - Francia 72
SE - Svezia 72
GB - Regno Unito 68
DE - Germania 66
NL - Olanda 62
CA - Canada 49
FI - Finlandia 44
IN - India 41
ES - Italia 21
JP - Giappone 18
PL - Polonia 17
TR - Turchia 17
IQ - Iraq 14
MX - Messico 14
AR - Argentina 13
AT - Austria 11
EC - Ecuador 11
IE - Irlanda 11
ZA - Sudafrica 10
AE - Emirati Arabi Uniti 8
LT - Lituania 8
BE - Belgio 7
CR - Costa Rica 7
EG - Egitto 7
ID - Indonesia 7
AU - Australia 6
CO - Colombia 6
MY - Malesia 6
PK - Pakistan 6
IL - Israele 5
PH - Filippine 5
PY - Paraguay 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KR - Corea 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
UA - Ucraina 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
JM - Giamaica 3
KE - Kenya 3
MD - Moldavia 3
TN - Tunisia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
LV - Lettonia 2
MA - Marocco 2
NP - Nepal 2
PR - Porto Rico 2
AL - Albania 1
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HT - Haiti 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
NI - Nicaragua 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZW - Zimbabwe 1
Totale 5.890
Salva come PNG Salva come JPEG
Città #
Singapore 323
Moscow 229
Ashburn 220
Dallas 178
Milan 168
San Jose 157
Hong Kong 153
Council Bluffs 100
New York 97
Beijing 74
Rome 70
Shanghai 69
Los Angeles 61
Santa Clara 59
Lauterbourg 41
Hefei 40
Ho Chi Minh City 38
Naples 36
Hanoi 28
Buffalo 26
Orem 25
São Paulo 23
Boardman 22
Turku 21
Munich 20
Bari 19
Turin 19
Brescia 17
Brooklyn 17
Bologna 16
Lawrence 16
Princeton 16
Chennai 15
Montreal 15
Toronto 15
Denver 14
Frankfurt am Main 14
Atlanta 13
Helsinki 13
Warsaw 13
Tokyo 12
Dublin 11
Manchester 11
Phoenix 11
Poplar 11
Suzhou 11
Washington 11
Chicago 10
Seattle 10
Valencia 10
Amsterdam 9
Mexico City 9
Nuremberg 9
Palermo 9
Ankara 8
Catania 8
Stockholm 8
Belo Horizonte 7
Genoa 7
Guangzhou 7
Lappeenranta 7
Miami 7
Mumbai 7
Padova 7
The Dalles 7
Tianjin 7
Baghdad 6
Barnet 6
Boston 6
Charleston 6
Columbus 6
Damietta 6
Falkenstein 6
Figino 6
London 6
Memphis 6
Omaha 6
Quito 6
Birmingham 5
Brussels 5
Changsha 5
Da Nang 5
Dhaka 5
Florence 5
Houston 5
Rio de Janeiro 5
San José 5
Trieste 5
Abu Dhabi 4
Asunción 4
Auckland 4
Bar Harbor 4
Bergamo 4
Bexley 4
Bolzano 4
Cesano Boscone 4
Erbil 4
Fortaleza 4
Haiphong 4
Jiaxing 4
Totale 2.911
Salva come PNG Salva come JPEG
Nome #
Simplification of prostate MRI protocol and development of a novel MRI technique for prostate cancer detection and characterization 400
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 252
ESR Essentials: using the right scoring system in prostate MRI—practice recommendations by ESUR 193
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 189
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 178
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 168
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 163
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 146
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 136
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 134
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 130
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 127
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 127
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 125
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 124
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 124
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 124
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 119
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 118
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-13 C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade 118
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 116
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 111
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 109
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 106
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 103
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 100
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 96
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 93
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 93
Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness 92
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 90
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 89
Beyond diagnosis: is there a role for radiomics in prostate cancer management? 88
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 81
AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance Images 77
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 77
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 76
Embolization of superior rectal arteries for transfusion dependent haemorrhoidal bleeding in severely cardiopathic patients: a new field of application of the “emborrhoid” technique 74
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 73
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 70
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer 69
US/TOF-PET endorectal probe compatible with MR, for diagnosis and staging of the prostate cancer 62
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial 59
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection 58
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI 54
Global Variation in Magnetic Resonance Imaging Quality of the Prostate 52
MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer? 50
Tackling Interobserver Variability in Multiparametric Magnetic Resonance Imaging (MRI): Is MRI Even Better than We Think for Prostate Cancer Diagnosis? 47
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging 46
Less Is More: Enhancing Prostate MRI Without Intravenous Contrast 45
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study 44
Diagnostic accuracy of abbreviated biparametric MRI for prostate cancer screening: a prospective feasibility study (ReIMAGINE study) 43
Therapeutic EUS: Biliary drainage - The interventional radiologist's perspective 43
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer 42
Is MRI ready to replace biopsy during active surveillance? 36
Diagnostic Accuracy of Fully Hybrid PET/MRI with [68 Ga]Ga-PSMA-11 and [68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 36
Dissemination of endometrial cancer MRI staging guidelines among young radiologists: an ESUR Junior Network survey 34
Improving image quality in prostate MRI: the time is now 34
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study 34
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer: An International, Paired, Noninferiority, Confirmatory Observer Study 31
Extraprostatic incidental findings on prostate mpMRI: A pictorial review from the ESUR junior network 31
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 27
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: A prospective cohort study 21
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score 18
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses 18
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer 11
PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI 11
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer 8
Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 study 6
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer 5
Totale 6.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 4 1 2 0 1 3 1 0 0 0 0
2022/2023183 40 22 13 10 3 13 10 13 4 5 32 18
2023/2024363 6 22 36 33 28 76 10 30 5 40 31 46
2024/2025911 68 29 35 43 72 89 140 99 117 48 86 85
2025/20264.033 209 177 194 318 387 184 341 372 1.135 296 208 212
2026/2027561 288 273 0 0 0 0 0 0 0 0 0 0
Totale 6.084